IL115861A - Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome - Google Patents
Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndromeInfo
- Publication number
- IL115861A IL115861A IL115861A IL11586192A IL115861A IL 115861 A IL115861 A IL 115861A IL 115861 A IL115861 A IL 115861A IL 11586192 A IL11586192 A IL 11586192A IL 115861 A IL115861 A IL 115861A
- Authority
- IL
- Israel
- Prior art keywords
- infants
- pharmaceutical formulation
- risk
- treatment
- death syndrome
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A pharmaceutical formulation, for the prevention of sudden infant death syndrome in infants shown to have a deficient plasma melatonin level, which comprises melatonin in combination with at least one pharmaceutical carrier, diluent or coating.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL10341192A IL103411A (en) | 1992-10-11 | 1992-10-11 | Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans |
Publications (1)
Publication Number | Publication Date |
---|---|
IL115861A true IL115861A (en) | 1997-04-15 |
Family
ID=11064108
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10341192A IL103411A (en) | 1992-10-11 | 1992-10-11 | Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans |
IL115861A IL115861A (en) | 1992-10-11 | 1992-10-14 | Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10341192A IL103411A (en) | 1992-10-11 | 1992-10-11 | Pharmaceutical formulation for controlled-release of melatonin for use in correcting a melatonin deficiency or distortion in the plasma melatonin level and profile in humans |
Country Status (1)
Country | Link |
---|---|
IL (2) | IL103411A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL144900A (en) | 2001-08-14 | 2013-12-31 | Neurim Pharma 1991 | Melatonin and medicaments comprising it for use in treating primary insomnia and in the manufacture of such medicaments |
CN104840439B (en) * | 2014-02-17 | 2019-07-23 | 中国科学院上海药物研究所 | A kind of bionical drug release preparation of epiphysin and preparation method thereof |
-
1992
- 1992-10-11 IL IL10341192A patent/IL103411A/en active Protection Beyond IP Right Term
- 1992-10-14 IL IL115861A patent/IL115861A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL103411A0 (en) | 1993-05-13 |
IL103411A (en) | 1996-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4285596A (en) | Sudden infant death syndrome prevention apparatus | |
LU91378I2 (en) | Melatonin circadin | |
FI941452A0 (en) | Compounds that increase the antitumor activity of other cytotoxic agents | |
IL100942A0 (en) | 2,4-diaminoquinazoline derivatives for enhancing antitumor activity | |
NO952237D0 (en) | Synthetic catalytic free radical scavengers useful as antioxidants for disease prevention and therapy | |
HUT67742A (en) | Phosphono-oxymethyl-ethers of taxane derivatives | |
GR3004966T3 (en) | ||
DK0612248T3 (en) | Composition containing cisplatin and topotecan as antitumor agent | |
ZA894392B (en) | Pharmaceutical products | |
GB9212308D0 (en) | Therapeutic compositions | |
MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
EP0610519A4 (en) | Anti-hiv drug. | |
AU641279B2 (en) | Oligosaccharide derivatives | |
DK0583026T3 (en) | ||
EP0592903A3 (en) | Use of ancrod for the preparation of drugs for the treatment of restenosis. | |
EP0676951A4 (en) | Use of vitamin d glycosides for the treatment or prevention of osteoporosis. | |
IL115861A (en) | Pharmaceutical formulation for the treatment of infants in risk of sudden infant death syndrome | |
GR3034757T3 (en) | Compositons for the treatment of chronic fatigue syndrome. | |
EP0284405A3 (en) | Anti-viral compounds, dosage forms and methods | |
GR3024028T3 (en) | Cytotoxic and antiviral compound. | |
UA41285C2 (en) | Creatine phosphate and pharmaceutically acceptable salts thereof for cancer treatment and pharmaceutical composition possessing anticancer activity | |
IL107017A0 (en) | Thiomarinol derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
DZ3208A1 (en) | Low dose tablets and preparation process. | |
EP0647135A4 (en) | Bis-(substituted-phenyl) derivatives with cytotoxic and anticancer activity. | |
NZ501365A (en) | Use of low-molecular-weight heparins for preventing and treating central nervous system (CNS) trauma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees | ||
NE | Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967) | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |